New study aims to reduce allergic reactions in stem cell therapy for multiple myeloma

NCT ID NCT07101445

Recruiting now Symptom relief Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether methylprednisolone works better than dexamethasone at preventing allergic reactions to motixafortide, a drug used to help collect stem cells for transplant in multiple myeloma patients. About 94 adults with multiple myeloma will be randomly assigned to receive one of the two premedication drugs before motixafortide. The goal is to find which regimen causes fewer and less severe reactions, improving the safety of stem cell collection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Emory University Hospital/Winship Cancer Institute
RECRUITING

Atlanta, Georgia, 30322, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact